Richard Leo Wahl

Richard Leo Wahl, MD

  • Radiology

Sees Patients For

PET/CT imaging, radiopharmaceutical therapies, nuclear Imaging

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital

Board Certifications

  • Nuclear Medicine
  • Diagnostic Radiology

Academic Title(s)

Elizabeth Mallinckrodt Professor, Radiology
Chairman, Department of Radiology
Director, Mallinckrodt Institute of Radiology

Languages

  • English

Education

Medical Degree

1978 Washington University School of Medicine, St. Louis, MO

ScD

2008 Wartburg College, Waverly, IA

Fellowship, Nuclear Medicine

1983 Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO

Fellowship (research), Immunology

1983 Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO

BA, Chemistry

1974 Wartburg College, Waverly, IA

Residency, Diagnostic Radiology

1982 Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO

Research Interests

Quantitative imaging, radioimmunotherapy, imaging the immune system, multi-modality imaging

Publications & Research

Search PubMed for publications »

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Company Name: Clarity PharmaceuticalsRoyalties: $1 - $9,999Equity: NoConsulting/Advisory Board: $20,000 - $39,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2020